**Core Concept**
The management of Congestive Heart Failure (CHF) involves a multi-faceted approach, including pharmacological interventions aimed at reducing mortality and morbidity. This involves the use of evidence-based medications that target the pathophysiological mechanisms underlying CHF, including neurohormonal activation, vasoconstriction, and fluid overload.

**Why the Correct Answer is Right**
The primary goal of CHF management is to reduce the workload on the heart and improve cardiac output. This is achieved through the use of vasodilators, diuretics, and inotropes. **ACE inhibitors**, such as lisinopril, work by blocking the conversion of angiotensin I to angiotensin II, thereby reducing vasoconstriction and decreasing afterload. **Beta-blockers**, such as metoprolol, slow heart rate and reduce contractility, which decreases oxygen demand and improves cardiac function.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to CHF management.
**Option B:** This option is incorrect as it does not address the pathophysiology of CHF.
**Option C:** This option is incorrect as it is not a commonly used medication in CHF management.

**Clinical Pearl / High-Yield Fact**
One key point to remember is that **ACE inhibitors should be started in CHF patients as soon as possible after diagnosis**, as they have been shown to reduce mortality and morbidity in this patient population.

**Correct Answer:** A. ACE inhibitors, such as lisinopril, are a cornerstone of CHF management.